Inhibition of leukemic cell telomerase activity by antisense phosphorothioate oligodeoxynucleotides
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hanish JP, Yanowitz JL, de Lange T. Stringent requiements for the formation of human telomeres. Proc Natl Acad Sci, 1994, 91(19): 8861–8865.
Kim NW. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 226 (5193): 2011–2015.
Sprung CN, Afshar G, Chavez EA, et al. Telomere instability in a human cancer cell line. Mutat Res, 1999, 429 (2): 209–223.
Kondo S, Kondo Y, Li GY, et al. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 1998, 16 (25): 3323–3330.
Masutomi K, Kaneko S, Hayashi N, et al. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J Biol Chem, 2000, 275 (29): 22568–22573.
Weinrich SL, Pruzan R, Ma LB, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunits hTRT. Nature Genetics, 1997, 17 (4): 498–502.
Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immunotalization. Cell, 1997, 90 (4): 785–795.
Yakakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res, 1998, 58 (7): 1558–1561.
Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT(hEST2), the catalytic subunit of telomerase. Oncogene, 1998, 16 (9): 1217–1222.
Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science, 1998, 279 (5349): 349–352.
Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTERT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet, 1998, 18 (1): 65–68.
Akoao Y, Mizoguchi H, Misiura K, et al. Antisense oligodeoxyribo-nucleotide against the MLL-LTG19 chimeric transcript inhibits cell line growth and induces apoptosis in cells of an infantile leukemia cell line carrying the t (II; 19) chromosomal translacation. Cancer Res, 1998, 58 (17): 3773–3776.
Yu WQ, Sun BZ, Chen Z. Effect of antisense oligodeoxynucleotide (A-SODN) to PML-RARα fusion gene on acute promyelocytic leukemia cell line NB4. Chin J Hematol, 1998, 19 (5): 227–230.
Thierry AR, Rahman A, Dritschilo A. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem Biophys Res Commun, 1993, 190 (3): 952–960.